The contract manufacturer Catalent sent a letter to its customers Monday seeking to reassure them that little will change ...

The team at Seaport Therapeutics, a Boston neuropsychiatry biotech, is having a good fall season. Seaport said Monday it has ...

Vertex detailed Phase 3 data for its non-opioid treatment that could mark a drastic shift in pain management. The company ...

Novartis has lost its legal challenge against the Inflation Reduction Act on Friday, making it the sixth drugmaker rejected ...